← Leaderboards
Steven G. Self
Fred Hutchinson Cancer Research Center
$87,296,645
Attributed
$87,296,645
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.4M · FY2005–16$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$87,296,645 · 7
By mechanism
U01$85,588,282 · 2
N01$852,857 · 1
R01$784,315 · 2
P01$71,191 · 2
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Rachel M. Ceballos$2,516,422
- Parveen Bhatti$2,980,595
- Suresh H Moolgavkar$4,311,665
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsData ManagementStatistical Service /CenterAids VaccinesClinical ResearchAids Education /PreventionClinical Trial Phase IMeasurementInfectionUnited States National Institutes Of HealthAids TherapyHuman SubjectHuman DataResponseHuman Therapy EvaluationAntigensAidsEnrollmentCooperative StudyAntibodiesEvaluationHuman Immunodeficiency Virus 1Immune ResponseVaccination
Grant awards (19)
The impact of prenatal exposure to persistent organic pollutants on kinetics of immune response to vaccines and sero-protection in infants$614,618
R01 · FY2016 · ES · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network$12,347,128
U01 · FY2010 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network$8,761,372
U01 · FY2009 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network$14,380,617
U01 · FY2008 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network$8,458,351
U01 · FY2007 · AI · contact PI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network$9,861,999
U01 · FY2006 · AI · contact PI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$1,536,651
U01 · FY2006 · AI · contact PI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$5,674,862
U01 · FY2005 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$5,513,907
U01 · FY2004 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$5,370,001
U01 · FY2003 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$5,093,154
U01 · FY2002 · AI
Core--Bioinformatics and Biostatistics$0
P01 · FY2002 · CA
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$4,753,232
U01 · FY2001 · AI
QUANTITATIVE METHOD FOR MODELING HIV INFECTION DYNAMICS$86,102
R01 · FY2001 · AI
HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP$3,837,008
U01 · FY2000 · AI
STATISTICAL &CLINICAL COORDINATING CENTER (SC)$852,857
N01 · FY2000 · AI
QUANTITATIVE METHOD FOR MODELING HIV INFECTION DYNAMICS$83,595
R01 · FY2000 · AI
QUANTITATIVE METHODS FOR MODELING HIV INFECTION DYNAMICS$71,191
P01 · FY2000 · CA
STATISTICAL &CLINICAL COORDINATING CENTER (SC)$0
N01 · FY2000 · AI